Applicant, as named in the Orange Book

Vivus Llc

Next listed expiry: Qsymia on 14 Jun 2029. 1 products with live protection, 1 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Qsymia · 4 strengths phentermine hydrochloride; topiramate	phentermine hydrochloride; topiramate	022580	14 Jun 2029	patent, carve-out possible

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.

Products without listed protection (1)

Drug	Ingredient	NDA	Earliest generic entry	Basis
Stendra · 3 strengths avanafil	avanafil	202276	open now	no listed protection